MolNFT v1 · #136888 · protein
Crystal structure of human caspase-7 soaked with allosteric inhibitor 2-[(2-ACETYLPHENYL)SULFANYL]BENZOIC acid
5V6U: “Crystal structure of human caspase-7 soaked with allosteric inhibitor 2-[(2-ACETYLPHENYL)SULFANYL]BENZOIC acid”. X-ray diffraction, 1 ligand (8YM), 2 pockets (best druggability 0.66). MolNFT v1 #136888 on GenesisL1: 3D structure…
- PDB
- 5V6U
- Type
- protein
- Length
- 418 residues
- Chains
- 2
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Caspase-7
- EC
- 3.4.22.60
- UniProt
- P55210
- Ligands
- 8YM
- Pockets
- 2 · best druggability 0.66
Structure
x-ray diffraction · 2 distinct chains · 32% helix, 27% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Caspase-7 (EC 3.4.22.60) | protein | 205 | 32% helix, 28% strand | P55210 |
| B | Caspase-7 (EC 3.4.22.60) | protein | 213 | 33% helix, 26% strand | P55210 |
Ligands and binding sites
- 8YM · 2-[(2-acetylphenyl)sulfanyl]benzoic acid · ligand · chains B
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 621 | 0.66 | 0.76 | 45 | 8YM |
| 2 | 50 | 0.33 | 0.78 | 14 | empty |
Interfaces
1 interface between chains.
- A–B · 1407 Ų buried · 20 hydrogen bonds · protein-protein
Modifications
Observed in the structure: 2 disulfide (disulfide).
Compared structures
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P55210
- Elsewhere: RCSB PDB 5V6U · PDBe 5V6U · UniProt P55210
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.